Rank | Gene Set | Z-score |
---|---|---|
1 | DNA unwinding involved in DNA replication (GO:0006268) | 4.43022694 |
2 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 4.42843418 |
3 | regulation of translational termination (GO:0006449) | 4.39952677 |
4 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.26857104 |
5 | NIK/NF-kappaB signaling (GO:0038061) | 4.21946531 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.12247655 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.12247655 |
8 | modulation by symbiont of host immune response (GO:0052553) | 4.12247655 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.12247655 |
10 | modulation by symbiont of host defense response (GO:0052031) | 4.12247655 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.12247655 |
12 | mitotic nuclear envelope disassembly (GO:0007077) | 4.02870030 |
13 | protein localization to kinetochore (GO:0034501) | 3.95995667 |
14 | heterochromatin organization (GO:0070828) | 3.94025379 |
15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.83584663 |
16 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.81662274 |
17 | membrane disassembly (GO:0030397) | 3.80736245 |
18 | nuclear envelope disassembly (GO:0051081) | 3.80736245 |
19 | maturation of SSU-rRNA (GO:0030490) | 3.77168622 |
20 | pre-miRNA processing (GO:0031054) | 3.72859425 |
21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.72528819 |
22 | positive thymic T cell selection (GO:0045059) | 3.68236019 |
23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.68016741 |
24 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.64152932 |
25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.62410734 |
26 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.56969592 |
27 | nucleobase biosynthetic process (GO:0046112) | 3.55561725 |
28 | negative regulation of interleukin-12 production (GO:0032695) | 3.51788938 |
29 | formation of translation preinitiation complex (GO:0001731) | 3.48308306 |
30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.41447555 |
31 | regulation of translational fidelity (GO:0006450) | 3.37734399 |
32 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.32728515 |
33 | ncRNA 3-end processing (GO:0043628) | 3.32667306 |
34 | peptidyl-arginine N-methylation (GO:0035246) | 3.32660211 |
35 | peptidyl-arginine methylation (GO:0018216) | 3.32660211 |
36 | maternal placenta development (GO:0001893) | 3.30720462 |
37 | response to peptidoglycan (GO:0032494) | 3.30587988 |
38 | folic acid metabolic process (GO:0046655) | 3.28128610 |
39 | DNA replication checkpoint (GO:0000076) | 3.25983563 |
40 | nuclear pore complex assembly (GO:0051292) | 3.25651670 |
41 | nuclear envelope organization (GO:0006998) | 3.23772124 |
42 | macrophage activation involved in immune response (GO:0002281) | 3.22327767 |
43 | T cell migration (GO:0072678) | 3.21439823 |
44 | positive regulation of protein homooligomerization (GO:0032464) | 3.21242526 |
45 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.21158283 |
46 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.16134822 |
47 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.15529177 |
48 | nuclear pore organization (GO:0006999) | 3.12555252 |
49 | protein localization to chromosome, centromeric region (GO:0071459) | 3.11821903 |
50 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.10960716 |
51 | DNA replication initiation (GO:0006270) | 3.10015864 |
52 | mitotic G1/S transition checkpoint (GO:0044819) | 3.09743382 |
53 | viral transcription (GO:0019083) | 3.09200083 |
54 | response to muramyl dipeptide (GO:0032495) | 3.07203900 |
55 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06683445 |
56 | regulation of protein heterodimerization activity (GO:0043497) | 3.05385475 |
57 | type I interferon signaling pathway (GO:0060337) | 3.03289203 |
58 | cellular response to type I interferon (GO:0071357) | 3.03289203 |
59 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.03002329 |
60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.02883149 |
61 | negative thymic T cell selection (GO:0045060) | 3.02877800 |
62 | translational initiation (GO:0006413) | 3.01174843 |
63 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01079773 |
64 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.01047848 |
65 | ribosome biogenesis (GO:0042254) | 3.00122832 |
66 | DNA strand elongation (GO:0022616) | 3.00052732 |
67 | translational termination (GO:0006415) | 2.99856304 |
68 | cellular response to interleukin-15 (GO:0071350) | 2.99513185 |
69 | thymic T cell selection (GO:0045061) | 2.99395413 |
70 | translational elongation (GO:0006414) | 2.98360209 |
71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.98174748 |
72 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.97869907 |
73 | immunoglobulin mediated immune response (GO:0016064) | 2.96735761 |
74 | mRNA stabilization (GO:0048255) | 2.95104375 |
75 | RNA stabilization (GO:0043489) | 2.95104375 |
76 | response to type I interferon (GO:0034340) | 2.95040835 |
77 | negative T cell selection (GO:0043383) | 2.94379592 |
78 | regulation of T cell tolerance induction (GO:0002664) | 2.94126478 |
79 | regulation of chromatin binding (GO:0035561) | 2.92033235 |
80 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.91208385 |
81 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.91208385 |
82 | germinal center formation (GO:0002467) | 2.90295859 |
83 | positive regulation of B cell differentiation (GO:0045579) | 2.89257137 |
84 | detection of molecule of bacterial origin (GO:0032490) | 2.87774722 |
85 | leukocyte aggregation (GO:0070486) | 2.87352366 |
86 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.87167493 |
87 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.87110863 |
88 | response to host immune response (GO:0052572) | 2.87110863 |
89 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.87003259 |
90 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.87003259 |
91 | endothelial cell chemotaxis (GO:0035767) | 2.86719235 |
92 | purine nucleobase biosynthetic process (GO:0009113) | 2.85738972 |
93 | T cell apoptotic process (GO:0070231) | 2.85614345 |
94 | IMP biosynthetic process (GO:0006188) | 2.84912433 |
95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.84598812 |
96 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.83212820 |
97 | detection of other organism (GO:0098543) | 2.80915867 |
98 | histone arginine methylation (GO:0034969) | 2.80859191 |
99 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.80758642 |
100 | DNA duplex unwinding (GO:0032508) | 2.76386390 |
101 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.76242091 |
102 | response to interleukin-15 (GO:0070672) | 2.73637222 |
103 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.73548167 |
104 | DNA geometric change (GO:0032392) | 2.72258035 |
105 | dosage compensation (GO:0007549) | 2.72233815 |
106 | peptidyl-lysine dimethylation (GO:0018027) | 2.70169401 |
107 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69714093 |
108 | negative regulation of cell killing (GO:0031342) | 2.69610960 |
109 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.69610960 |
110 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.68438098 |
111 | negative regulation of histone methylation (GO:0031061) | 2.68350922 |
112 | histone H2A monoubiquitination (GO:0035518) | 2.67731239 |
113 | tolerance induction (GO:0002507) | 2.67562869 |
114 | myeloid dendritic cell differentiation (GO:0043011) | 2.67460667 |
115 | positive T cell selection (GO:0043368) | 2.67376857 |
116 | regulation of response to interferon-gamma (GO:0060330) | 2.66236337 |
117 | positive regulation of nuclease activity (GO:0032075) | 2.65831843 |
118 | mitotic chromosome condensation (GO:0007076) | 2.65755402 |
119 | regulation of RNA export from nucleus (GO:0046831) | 2.65613888 |
120 | mitotic sister chromatid segregation (GO:0000070) | 2.65410105 |
121 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.64422332 |
122 | cellular response to interleukin-4 (GO:0071353) | 2.63873508 |
123 | negative regulation of RNA splicing (GO:0033119) | 2.63521313 |
124 | * RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.62978173 |
125 | * mRNA splicing, via spliceosome (GO:0000398) | 2.62978173 |
126 | detection of bacterium (GO:0016045) | 2.62777283 |
127 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.62424354 |
128 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.62092828 |
129 | B cell receptor signaling pathway (GO:0050853) | 2.61947086 |
130 | detection of external biotic stimulus (GO:0098581) | 2.61833687 |
131 | tetrahydrofolate metabolic process (GO:0046653) | 2.61010507 |
132 | IMP metabolic process (GO:0046040) | 2.60180283 |
133 | * RNA splicing, via transesterification reactions (GO:0000375) | 2.60062050 |
134 | amino sugar catabolic process (GO:0046348) | 2.58988835 |
135 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.58988706 |
136 | regulation of defense response to virus by host (GO:0050691) | 2.58023096 |
137 | negative regulation of translational initiation (GO:0045947) | 2.57997294 |
138 | regulation of B cell differentiation (GO:0045577) | 2.57946727 |
139 | trophectodermal cell differentiation (GO:0001829) | 2.57940674 |
140 | regulation of tolerance induction (GO:0002643) | 2.57138593 |
141 | glycine metabolic process (GO:0006544) | 2.56671442 |
142 | natural killer cell differentiation (GO:0001779) | 2.56670271 |
143 | regulation of translational initiation (GO:0006446) | 2.56398996 |
144 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.55864296 |
145 | neutrophil activation involved in immune response (GO:0002283) | 2.55691050 |
146 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.55596648 |
147 | histone-serine phosphorylation (GO:0035404) | 2.55265170 |
148 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.55231448 |
149 | apoptotic process involved in morphogenesis (GO:0060561) | 2.54092975 |
150 | myeloid cell activation involved in immune response (GO:0002275) | 2.54022750 |
151 | protein complex disassembly (GO:0043241) | 2.53303767 |
152 | cellular protein complex disassembly (GO:0043624) | 2.53168556 |
153 | negative regulation of innate immune response (GO:0045824) | 2.52544457 |
154 | COPI coating of Golgi vesicle (GO:0048205) | 2.52465432 |
155 | cellular extravasation (GO:0045123) | 2.52206407 |
156 | myeloid dendritic cell activation (GO:0001773) | 2.52144492 |
157 | B cell homeostasis (GO:0001782) | 2.51486169 |
158 | response to protozoan (GO:0001562) | 2.51009824 |
159 | T cell selection (GO:0045058) | 2.50640507 |
160 | positive regulation of isotype switching (GO:0045830) | 2.49911068 |
161 | N-acetylneuraminate metabolic process (GO:0006054) | 2.49867222 |
162 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.48709883 |
163 | response to host (GO:0075136) | 2.48709883 |
164 | response to host defenses (GO:0052200) | 2.48709883 |
165 | negative regulation of interleukin-6 production (GO:0032715) | 2.48276067 |
166 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.45414249 |
167 | B cell mediated immunity (GO:0019724) | 2.44981917 |
168 | defense response to protozoan (GO:0042832) | 2.44723944 |
169 | positive regulation of interleukin-2 production (GO:0032743) | 2.44315363 |
170 | regulation of necroptotic process (GO:0060544) | 2.44011921 |
171 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.43491774 |
172 | macrophage activation (GO:0042116) | 2.41785834 |
173 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.41688471 |
174 | neutrophil mediated immunity (GO:0002446) | 2.40912096 |
175 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.39330345 |
176 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.37681702 |
177 | programmed necrotic cell death (GO:0097300) | 2.37171546 |
178 | granulocyte activation (GO:0036230) | 2.36303228 |
179 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.34023038 |
180 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.33569882 |
181 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.33275847 |
182 | regulation of isotype switching (GO:0045191) | 2.32502194 |
183 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.31604163 |
184 | T-helper 1 type immune response (GO:0042088) | 2.29893693 |
185 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.29688031 |
186 | T cell homeostasis (GO:0043029) | 2.29623497 |
187 | positive regulation of tolerance induction (GO:0002645) | 2.29494094 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.75818800 |
2 | MYC_22102868_ChIP-Seq_BL_Human | 3.57495343 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.57224554 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.36651466 |
5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.22330108 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.11113129 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.81975336 |
8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.78121429 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.74654447 |
10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.62530876 |
11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.57737132 |
12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50150881 |
13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39520872 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31897835 |
15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.30753510 |
16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20869468 |
17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.08967955 |
18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07849858 |
19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.99236795 |
20 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.98212058 |
21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.97221440 |
22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88347180 |
23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85001543 |
24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.83140387 |
25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83023174 |
26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79074745 |
27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.78982128 |
28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.77776973 |
29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77015326 |
30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75581957 |
31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.74987059 |
32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.74419453 |
33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72785214 |
34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.72142307 |
35 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.71883211 |
36 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.71821085 |
37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.70939932 |
38 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.70439260 |
39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64608202 |
40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60834947 |
41 | MAF_26560356_Chip-Seq_TH1_Human | 1.59000017 |
42 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58757051 |
43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.58632206 |
44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57813746 |
45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.56089779 |
46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55890218 |
47 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.54061688 |
48 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.51874773 |
49 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.51586894 |
50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.50980346 |
51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50092490 |
52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.48406353 |
53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47703676 |
54 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.46460087 |
55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45340174 |
56 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.44688510 |
57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44674965 |
58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43297709 |
59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42772555 |
60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42689133 |
61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42478511 |
62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41931331 |
63 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.37405802 |
64 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37085383 |
65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36807864 |
66 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.36509619 |
67 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.34226921 |
68 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34169015 |
69 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.33788551 |
70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.33385592 |
71 | MAF_26560356_Chip-Seq_TH2_Human | 1.29349514 |
72 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.28084526 |
73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27931160 |
74 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27908869 |
75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26720506 |
76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25013713 |
77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24775913 |
78 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.24561058 |
79 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.23881176 |
80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23005556 |
81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22931714 |
82 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.22547932 |
83 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21898542 |
84 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21830280 |
85 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21380094 |
86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21309575 |
87 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21191905 |
88 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21179155 |
89 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.20886093 |
90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20705323 |
91 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20083539 |
92 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19348665 |
93 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18702555 |
94 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.18344401 |
95 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.18040072 |
96 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.17687806 |
97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17670764 |
98 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17065863 |
99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15673381 |
100 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.15571454 |
101 | P68_20966046_ChIP-Seq_HELA_Human | 1.14887607 |
102 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.14775078 |
103 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14527888 |
104 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.13593289 |
105 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13213452 |
106 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.13174232 |
107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12764522 |
108 | MYB_26560356_Chip-Seq_TH1_Human | 1.12680775 |
109 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12597755 |
110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11521039 |
111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11253505 |
112 | MYB_26560356_Chip-Seq_TH2_Human | 1.10981074 |
113 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10451426 |
114 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09999748 |
115 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08867534 |
116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08310307 |
117 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07419778 |
118 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07352652 |
119 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.06945387 |
120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06739732 |
121 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06625842 |
122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05241689 |
123 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03790097 |
124 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03120567 |
125 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02963785 |
126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02755287 |
127 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02698302 |
128 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.01628602 |
129 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00664518 |
130 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99975326 |
131 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99456774 |
132 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99234942 |
133 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97645105 |
134 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97247749 |
135 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95199188 |
136 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94888215 |
137 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94332088 |
138 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94079860 |
139 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93608067 |
140 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.93013772 |
141 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92448805 |
142 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91888610 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 3.09173610 |
2 | MP0003111_abnormal_nucleus_morphology | 2.97183425 |
3 | MP0003705_abnormal_hypodermis_morpholog | 2.91412492 |
4 | MP0010352_gastrointestinal_tract_polyps | 2.82574326 |
5 | MP0003303_peritoneal_inflammation | 2.82530030 |
6 | MP0009840_abnormal_foam_cell | 2.72664473 |
7 | MP0005451_abnormal_body_composition | 2.67502066 |
8 | MP0005076_abnormal_cell_differentiation | 2.67063734 |
9 | MP0003077_abnormal_cell_cycle | 2.50799424 |
10 | MP0004957_abnormal_blastocyst_morpholog | 2.43668379 |
11 | MP0003724_increased_susceptibility_to | 2.40457805 |
12 | MP0010094_abnormal_chromosome_stability | 2.33353587 |
13 | MP0000015_abnormal_ear_pigmentation | 2.29214309 |
14 | MP0008260_abnormal_autophagy | 2.26266609 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.23639724 |
16 | MP0009785_altered_susceptibility_to | 2.17395541 |
17 | MP0001730_embryonic_growth_arrest | 2.16516899 |
18 | MP0002419_abnormal_innate_immunity | 2.16101421 |
19 | MP0002653_abnormal_ependyma_morphology | 2.14212613 |
20 | MP0005025_abnormal_response_to | 2.06527515 |
21 | MP0003300_gastrointestinal_ulcer | 2.03568645 |
22 | MP0003763_abnormal_thymus_physiology | 2.01711375 |
23 | MP0005075_abnormal_melanosome_morpholog | 1.99210879 |
24 | MP0008961_abnormal_basal_metabolism | 1.99024359 |
25 | MP0000685_abnormal_immune_system | 1.92432262 |
26 | MP0004381_abnormal_hair_follicle | 1.90862354 |
27 | MP0009333_abnormal_splenocyte_physiolog | 1.89738032 |
28 | MP0000350_abnormal_cell_proliferation | 1.88531611 |
29 | MP0002132_abnormal_respiratory_system | 1.85105028 |
30 | MP0008057_abnormal_DNA_replication | 1.83250723 |
31 | MP0010307_abnormal_tumor_latency | 1.81937988 |
32 | MP0003123_paternal_imprinting | 1.81592126 |
33 | MP0000703_abnormal_thymus_morphology | 1.78733845 |
34 | MP0004510_myositis | 1.75285987 |
35 | MP0008007_abnormal_cellular_replicative | 1.70403920 |
36 | MP0002877_abnormal_melanocyte_morpholog | 1.70194446 |
37 | MP0003566_abnormal_cell_adhesion | 1.67773012 |
38 | MP0001853_heart_inflammation | 1.67464677 |
39 | MP0002396_abnormal_hematopoietic_system | 1.67415556 |
40 | MP0003984_embryonic_growth_retardation | 1.64474633 |
41 | MP0002088_abnormal_embryonic_growth/wei | 1.63922490 |
42 | MP0009278_abnormal_bone_marrow | 1.63437487 |
43 | MP0009764_decreased_sensitivity_to | 1.62965723 |
44 | MP0001672_abnormal_embryogenesis/_devel | 1.60528484 |
45 | MP0005380_embryogenesis_phenotype | 1.60528484 |
46 | MP0003656_abnormal_erythrocyte_physiolo | 1.58971197 |
47 | MP0002398_abnormal_bone_marrow | 1.58822913 |
48 | MP0001849_ear_inflammation | 1.56579482 |
49 | MP0001697_abnormal_embryo_size | 1.55779875 |
50 | MP0004808_abnormal_hematopoietic_stem | 1.55096154 |
51 | MP0004947_skin_inflammation | 1.53015435 |
52 | MP0008932_abnormal_embryonic_tissue | 1.51251132 |
53 | MP0005310_abnormal_salivary_gland | 1.49832364 |
54 | MP0005023_abnormal_wound_healing | 1.48564738 |
55 | MP0002722_abnormal_immune_system | 1.48427694 |
56 | MP0002080_prenatal_lethality | 1.48418952 |
57 | MP0003806_abnormal_nucleotide_metabolis | 1.46713620 |
58 | MP0006035_abnormal_mitochondrial_morpho | 1.46216430 |
59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.46038403 |
60 | MP0003828_pulmonary_edema | 1.45263348 |
61 | MP0000569_abnormal_digit_pigmentation | 1.44324045 |
62 | MP0001800_abnormal_humoral_immune | 1.40215921 |
63 | MP0000689_abnormal_spleen_morphology | 1.38772582 |
64 | MP0003646_muscle_fatigue | 1.37562573 |
65 | MP0000372_irregular_coat_pigmentation | 1.37481608 |
66 | MP0000490_abnormal_crypts_of | 1.35431058 |
67 | MP0000465_gastrointestinal_hemorrhage | 1.33127593 |
68 | MP0003436_decreased_susceptibility_to | 1.33089457 |
69 | MP0001545_abnormal_hematopoietic_system | 1.32575496 |
70 | MP0005397_hematopoietic_system_phenotyp | 1.32575496 |
71 | MP0000858_altered_metastatic_potential | 1.30200602 |
72 | MP0002086_abnormal_extraembryonic_tissu | 1.29261323 |
73 | MP0002405_respiratory_system_inflammati | 1.28685434 |
74 | MP0004197_abnormal_fetal_growth/weight/ | 1.26615145 |
75 | MP0001533_abnormal_skeleton_physiology | 1.25833156 |
76 | MP0002019_abnormal_tumor_incidence | 1.24339443 |
77 | MP0000716_abnormal_immune_system | 1.24096068 |
78 | MP0002277_abnormal_respiratory_mucosa | 1.22205225 |
79 | MP0002429_abnormal_blood_cell | 1.21571207 |
80 | MP0005671_abnormal_response_to | 1.20856792 |
81 | MP0002723_abnormal_immune_serum | 1.19197202 |
82 | MP0002084_abnormal_developmental_patter | 1.19018184 |
83 | MP0002420_abnormal_adaptive_immunity | 1.18833223 |
84 | MP0002085_abnormal_embryonic_tissue | 1.18715638 |
85 | MP0002452_abnormal_antigen_presenting | 1.17845790 |
86 | MP0001819_abnormal_immune_cell | 1.17592651 |
87 | MP0001790_abnormal_immune_system | 1.16993749 |
88 | MP0005387_immune_system_phenotype | 1.16993749 |
89 | MP0008469_abnormal_protein_level | 1.16957760 |
90 | MP0005000_abnormal_immune_tolerance | 1.14085910 |
91 | MP0004233_abnormal_muscle_weight | 1.13540487 |
92 | MP0009672_abnormal_birth_weight | 1.13308796 |
93 | MP0000313_abnormal_cell_death | 1.12386943 |
94 | MP0005083_abnormal_biliary_tract | 1.10952229 |
95 | MP0000371_diluted_coat_color | 1.04756542 |
96 | MP0005621_abnormal_cell_physiology | 1.03908357 |
97 | MP0003191_abnormal_cellular_cholesterol | 1.02045619 |
98 | MP0002095_abnormal_skin_pigmentation | 1.01095506 |
99 | MP0000358_abnormal_cell_content/ | 1.00896519 |
100 | MP0003866_abnormal_defecation | 1.00703981 |
101 | MP0006082_CNS_inflammation | 0.99983967 |
102 | MP0002089_abnormal_postnatal_growth/wei | 0.99631931 |
103 | MP0002332_abnormal_exercise_endurance | 0.98350437 |
104 | MP0001348_abnormal_lacrimal_gland | 0.97910953 |
105 | MP0006036_abnormal_mitochondrial_physio | 0.97420175 |
106 | MP0000733_abnormal_muscle_development | 0.95208457 |
107 | MP0003091_abnormal_cell_migration | 0.95072977 |
108 | MP0008058_abnormal_DNA_repair | 0.93991406 |
109 | MP0005408_hypopigmentation | 0.93965406 |
110 | MP0001915_intracranial_hemorrhage | 0.92017029 |
111 | MP0003172_abnormal_lysosome_physiology | 0.90141413 |
112 | MP0003448_altered_tumor_morphology | 0.88887473 |
113 | MP0000609_abnormal_liver_physiology | 0.88816353 |
114 | MP0001835_abnormal_antigen_presentation | 0.87886347 |
115 | MP0000537_abnormal_urethra_morphology | 0.87437608 |
116 | MP0005464_abnormal_platelet_physiology | 0.87416471 |
117 | MP0008770_decreased_survivor_rate | 0.87315465 |
118 | MP0003186_abnormal_redox_activity | 0.86528449 |
119 | MP0003786_premature_aging | 0.86505313 |
120 | MP0005384_cellular_phenotype | 0.86148293 |
121 | MP0001873_stomach_inflammation | 0.85190760 |
122 | MP0002166_altered_tumor_susceptibility | 0.83872833 |
123 | MP0009053_abnormal_anal_canal | 0.83670096 |
124 | MP0002138_abnormal_hepatobiliary_system | 0.83409524 |
125 | MP0006054_spinal_hemorrhage | 0.83383527 |
126 | MP0005058_abnormal_lysosome_morphology | 0.82762543 |
127 | MP0005623_abnormal_meninges_morphology | 0.80930740 |
128 | MP0009765_abnormal_xenobiotic_induced | 0.80042054 |
129 | MP0010155_abnormal_intestine_physiology | 0.78155552 |
130 | MP0001845_abnormal_inflammatory_respons | 0.78082053 |
131 | MP0000604_amyloidosis | 0.77833868 |
132 | MP0000598_abnormal_liver_morphology | 0.76439488 |
133 | MP0003183_abnormal_peptide_metabolism | 0.76149922 |
134 | MP0003136_yellow_coat_color | 0.75331059 |
135 | MP0000477_abnormal_intestine_morphology | 0.74017096 |
136 | MP0010630_abnormal_cardiac_muscle | 0.73308778 |
137 | MP0002254_reproductive_system_inflammat | 0.72245301 |
138 | MP0001986_abnormal_taste_sensitivity | 0.71488918 |
139 | MP0000343_altered_response_to | 0.69128980 |
140 | MP0003453_abnormal_keratinocyte_physiol | 0.67752160 |
141 | MP0009763_increased_sensitivity_to | 0.66569890 |
142 | MP0003950_abnormal_plasma_membrane | 0.64978638 |
143 | MP0002006_tumorigenesis | 0.61300868 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 4.58977863 |
2 | Recurrent abscess formation (HP:0002722) | 4.35894901 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.24276620 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.24276620 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.24276620 |
6 | Eczematoid dermatitis (HP:0000976) | 3.91093568 |
7 | Abnormality of macrophages (HP:0004311) | 3.78024784 |
8 | Increased density of long bones (HP:0006392) | 3.66329747 |
9 | Stomatitis (HP:0010280) | 3.61811342 |
10 | Orchitis (HP:0100796) | 3.43465869 |
11 | Gastrointestinal infarctions (HP:0005244) | 3.42358063 |
12 | Hand muscle atrophy (HP:0009130) | 3.40427436 |
13 | Albinism (HP:0001022) | 3.35004063 |
14 | Upper limb amyotrophy (HP:0009129) | 3.27465876 |
15 | Distal upper limb amyotrophy (HP:0007149) | 3.27465876 |
16 | Vacuolated lymphocytes (HP:0001922) | 3.26446396 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.21651824 |
18 | Optic neuritis (HP:0100653) | 3.16901209 |
19 | Retrobulbar optic neuritis (HP:0100654) | 3.16901209 |
20 | Microvesicular hepatic steatosis (HP:0001414) | 3.14731865 |
21 | Cerebral aneurysm (HP:0004944) | 3.03512811 |
22 | Abnormality of the lower motor neuron (HP:0002366) | 2.93168346 |
23 | Ragged-red muscle fibers (HP:0003200) | 2.90533625 |
24 | Autoimmune hemolytic anemia (HP:0001890) | 2.88749753 |
25 | Selective tooth agenesis (HP:0001592) | 2.84684263 |
26 | Increased cerebral lipofuscin (HP:0011813) | 2.83172959 |
27 | Petechiae (HP:0000967) | 2.81749816 |
28 | Hyperacusis (HP:0010780) | 2.81377295 |
29 | Recurrent fungal infections (HP:0002841) | 2.80513932 |
30 | Nasal polyposis (HP:0100582) | 2.77361544 |
31 | Increased IgM level (HP:0003496) | 2.76134121 |
32 | Obstructive lung disease (HP:0006536) | 2.66934553 |
33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66934553 |
34 | Increased serum ferritin (HP:0003281) | 2.64537562 |
35 | Recurrent skin infections (HP:0001581) | 2.62149736 |
36 | Encephalitis (HP:0002383) | 2.61618170 |
37 | Pustule (HP:0200039) | 2.60365365 |
38 | Loss of speech (HP:0002371) | 2.58859205 |
39 | Deep palmar crease (HP:0006191) | 2.58760164 |
40 | Protrusio acetabuli (HP:0003179) | 2.58627463 |
41 | Abnormality of the anterior horn cell (HP:0006802) | 2.57334647 |
42 | Degeneration of anterior horn cells (HP:0002398) | 2.57334647 |
43 | Vasculitis (HP:0002633) | 2.56666867 |
44 | Achilles tendon contracture (HP:0001771) | 2.53576096 |
45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53482728 |
46 | Genu recurvatum (HP:0002816) | 2.53396744 |
47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.47911098 |
48 | Meningitis (HP:0001287) | 2.45878346 |
49 | Abnormality of the nasal mucosa (HP:0000433) | 2.42811115 |
50 | Progressive external ophthalmoplegia (HP:0000590) | 2.42489872 |
51 | Abnormality of T cell physiology (HP:0011840) | 2.42176425 |
52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.41546196 |
53 | Lymphopenia (HP:0001888) | 2.40083634 |
54 | Entropion (HP:0000621) | 2.39623397 |
55 | Ocular albinism (HP:0001107) | 2.38270123 |
56 | Difficulty climbing stairs (HP:0003551) | 2.36183207 |
57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.34888710 |
58 | Abnormality of the Achilles tendon (HP:0005109) | 2.33674813 |
59 | Carpal bone hypoplasia (HP:0001498) | 2.33486141 |
60 | Granulocytopenia (HP:0001913) | 2.33476442 |
61 | Hypokinesia (HP:0002375) | 2.32852797 |
62 | Osteomyelitis (HP:0002754) | 2.29663387 |
63 | Severe short stature (HP:0003510) | 2.29013481 |
64 | Hypochromic anemia (HP:0001931) | 2.28674353 |
65 | Urticaria (HP:0001025) | 2.28577293 |
66 | Premature rupture of membranes (HP:0001788) | 2.28062645 |
67 | Keratoconjunctivitis sicca (HP:0001097) | 2.27404581 |
68 | Persistence of primary teeth (HP:0006335) | 2.26959025 |
69 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26524260 |
70 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.26498929 |
71 | Dysostosis multiplex (HP:0000943) | 2.25926881 |
72 | Abnormality of the calcaneus (HP:0008364) | 2.22730802 |
73 | Inflammation of the large intestine (HP:0002037) | 2.22719498 |
74 | Chest pain (HP:0100749) | 2.19632393 |
75 | Autoimmune thrombocytopenia (HP:0001973) | 2.19336732 |
76 | Abnormal neuron morphology (HP:0012757) | 2.18977972 |
77 | Abnormality of the motor neurons (HP:0002450) | 2.18977972 |
78 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18663328 |
79 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18663328 |
80 | Progressive neurologic deterioration (HP:0002344) | 2.18247036 |
81 | Global brain atrophy (HP:0002283) | 2.16272005 |
82 | Shallow orbits (HP:0000586) | 2.15094052 |
83 | Abnormality of iron homeostasis (HP:0011031) | 2.14752437 |
84 | Keratoconjunctivitis (HP:0001096) | 2.12719719 |
85 | Thrombocytosis (HP:0001894) | 2.11968835 |
86 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.10194346 |
87 | Short 4th metacarpal (HP:0010044) | 2.10194346 |
88 | Increased IgE level (HP:0003212) | 2.09744974 |
89 | Cone-rod dystrophy (HP:0000548) | 2.09299001 |
90 | Acute hepatic failure (HP:0006554) | 2.08969416 |
91 | Cerebral hypomyelination (HP:0006808) | 2.07739583 |
92 | Metaphyseal cupping (HP:0003021) | 2.07312729 |
93 | Pulmonary infiltrates (HP:0002113) | 2.07083006 |
94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06157631 |
95 | Anhidrosis (HP:0000970) | 2.05761180 |
96 | Ulnar bowing (HP:0003031) | 2.04903650 |
97 | Limb-girdle muscle atrophy (HP:0003797) | 2.04725084 |
98 | Basal cell carcinoma (HP:0002671) | 2.04345782 |
99 | Personality changes (HP:0000751) | 2.02231482 |
100 | Leukocytosis (HP:0001974) | 2.02195092 |
101 | Gingivitis (HP:0000230) | 2.01866097 |
102 | Eosinophilia (HP:0001880) | 2.01190402 |
103 | Cervical subluxation (HP:0003308) | 2.01108113 |
104 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.00310494 |
105 | Colitis (HP:0002583) | 2.00237534 |
106 | Keratitis (HP:0000491) | 2.00134853 |
107 | Anorexia (HP:0002039) | 1.99448219 |
108 | Insomnia (HP:0100785) | 1.99408244 |
109 | Ependymoma (HP:0002888) | 1.98847287 |
110 | Fatigue (HP:0012378) | 1.98652225 |
111 | IgA deficiency (HP:0002720) | 1.98421688 |
112 | IgG deficiency (HP:0004315) | 1.98296243 |
113 | Rectal prolapse (HP:0002035) | 1.98084556 |
114 | Progressive muscle weakness (HP:0003323) | 1.98032875 |
115 | Abnormality of the fingertips (HP:0001211) | 1.95810633 |
116 | Multiple enchondromatosis (HP:0005701) | 1.94861616 |
117 | Pointed chin (HP:0000307) | 1.94419217 |
118 | Spastic diplegia (HP:0001264) | 1.93221753 |
119 | Slow saccadic eye movements (HP:0000514) | 1.90898122 |
120 | Bicuspid aortic valve (HP:0001647) | 1.90170630 |
121 | Reticulocytosis (HP:0001923) | 1.89168990 |
122 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88742264 |
123 | Pelvic girdle muscle weakness (HP:0003749) | 1.88372669 |
124 | Myositis (HP:0100614) | 1.87430429 |
125 | Amyotrophic lateral sclerosis (HP:0007354) | 1.87424530 |
126 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.87233189 |
127 | Trismus (HP:0000211) | 1.86830045 |
128 | Gastrointestinal stroma tumor (HP:0100723) | 1.86171252 |
129 | Chronic diarrhea (HP:0002028) | 1.84777881 |
130 | Iris hypopigmentation (HP:0007730) | 1.84744337 |
131 | High pitched voice (HP:0001620) | 1.82748092 |
132 | Cutaneous photosensitivity (HP:0000992) | 1.82173666 |
133 | Poor head control (HP:0002421) | 1.81779884 |
134 | Abnormal number of erythroid precursors (HP:0012131) | 1.80982489 |
135 | Deviation of the thumb (HP:0009603) | 1.80450945 |
136 | Abnormality of reticulocytes (HP:0004312) | 1.79910577 |
137 | Hypochromic microcytic anemia (HP:0004840) | 1.79864962 |
138 | Panhypogammaglobulinemia (HP:0003139) | 1.79440474 |
139 | Recurrent viral infections (HP:0004429) | 1.79127852 |
140 | T lymphocytopenia (HP:0005403) | 1.78935495 |
141 | Ankle contracture (HP:0006466) | 1.78047450 |
142 | Papilloma (HP:0012740) | 1.78040493 |
143 | Verrucae (HP:0200043) | 1.78040493 |
144 | Adenoma sebaceum (HP:0009720) | 1.77877803 |
145 | Angiofibromas (HP:0010615) | 1.77877803 |
146 | Prolonged neonatal jaundice (HP:0006579) | 1.77831103 |
147 | Hypertensive crisis (HP:0100735) | 1.77568678 |
148 | Vertebral arch anomaly (HP:0008438) | 1.77099697 |
149 | Mitral valve prolapse (HP:0001634) | 1.76724946 |
150 | Long palpebral fissure (HP:0000637) | 1.74991829 |
151 | Peripheral hypomyelination (HP:0007182) | 1.74727536 |
152 | Abnormality of eosinophils (HP:0001879) | 1.74230054 |
153 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73870287 |
154 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73870287 |
155 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73870287 |
156 | Cellulitis (HP:0100658) | 1.73463556 |
157 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.73198727 |
158 | Dysmetric saccades (HP:0000641) | 1.72328111 |
159 | IgM deficiency (HP:0002850) | 1.71036539 |
160 | Microretrognathia (HP:0000308) | 1.70994906 |
161 | Broad palm (HP:0001169) | 1.69920525 |
162 | Glossoptosis (HP:0000162) | 1.69473187 |
163 | Abnormality of the 4th metacarpal (HP:0010012) | 1.68785615 |
164 | Striae distensae (HP:0001065) | 1.68406352 |
165 | Renal duplication (HP:0000075) | 1.67944046 |
166 | Abnormality of T cells (HP:0002843) | 1.67506695 |
167 | Increased connective tissue (HP:0009025) | 1.66686389 |
168 | Radial bowing (HP:0002986) | 1.66513439 |
169 | Abnormality of the peritoneum (HP:0002585) | 1.65751222 |
170 | Gastrointestinal inflammation (HP:0004386) | 1.65137149 |
171 | Proximal placement of thumb (HP:0009623) | 1.64661241 |
172 | Reticulocytopenia (HP:0001896) | 1.63451175 |
173 | Agnosia (HP:0010524) | 1.63437414 |
174 | Dilatation of the ascending aorta (HP:0005111) | 1.62654139 |
175 | Annular pancreas (HP:0001734) | 1.62483944 |
176 | Patellar aplasia (HP:0006443) | 1.61971071 |
177 | Abnormality of T cell number (HP:0011839) | 1.60230267 |
178 | Pallor (HP:0000980) | 1.60056926 |
179 | Prominent nose (HP:0000448) | 1.59433738 |
180 | Neoplasm of the pancreas (HP:0002894) | 1.59181081 |
181 | Shoulder girdle muscle weakness (HP:0003547) | 1.58325385 |
182 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.57966448 |
183 | Increased nuchal translucency (HP:0010880) | 1.57108070 |
184 | Abnormal number of incisors (HP:0011064) | 1.56701734 |
185 | Missing ribs (HP:0000921) | 1.56637054 |
186 | Peritonitis (HP:0002586) | 1.55210456 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EEF2K | 3.98475424 |
2 | TRIB3 | 3.77544457 |
3 | MAP3K10 | 3.68075204 |
4 | IRAK3 | 3.19003922 |
5 | ERN1 | 2.87636401 |
6 | MAP3K14 | 2.85443598 |
7 | CDK12 | 2.61915759 |
8 | PRPF4B | 2.57897150 |
9 | PDK2 | 2.52287815 |
10 | MAP4K1 | 2.51877336 |
11 | TSSK6 | 2.47105948 |
12 | NEK2 | 2.37998295 |
13 | PKN2 | 2.24593135 |
14 | STK10 | 2.10228802 |
15 | IRAK4 | 2.04641076 |
16 | BUB1 | 2.02751176 |
17 | IKBKE | 1.95761050 |
18 | CDC7 | 1.95524384 |
19 | TLK1 | 1.87160485 |
20 | BLK | 1.70139341 |
21 | SCYL2 | 1.66782722 |
22 | SIK3 | 1.65687007 |
23 | TESK2 | 1.65606974 |
24 | CSK | 1.65514109 |
25 | TAOK1 | 1.60274296 |
26 | GRK6 | 1.55887183 |
27 | MAP2K3 | 1.52517139 |
28 | ALK | 1.49658162 |
29 | EIF2AK1 | 1.47808633 |
30 | SRPK1 | 1.47418912 |
31 | LRRK2 | 1.45261418 |
32 | CDK4 | 1.45147867 |
33 | RIPK4 | 1.44540037 |
34 | FES | 1.42606004 |
35 | TTN | 1.40813895 |
36 | PASK | 1.37387542 |
37 | NEK1 | 1.33746457 |
38 | WEE1 | 1.31430364 |
39 | MAP3K8 | 1.28387296 |
40 | PIK3CG | 1.27775805 |
41 | MAP3K13 | 1.24343712 |
42 | FGR | 1.23484919 |
43 | ICK | 1.21451743 |
44 | FGFR4 | 1.19618733 |
45 | PTK6 | 1.19599006 |
46 | JAK3 | 1.15160855 |
47 | ZAP70 | 1.12635667 |
48 | TBK1 | 1.11804797 |
49 | MAP3K11 | 1.11662672 |
50 | RPS6KA4 | 1.11150371 |
51 | MAP3K1 | 1.10430419 |
52 | BRD4 | 1.09026739 |
53 | NME2 | 1.08909048 |
54 | MAP3K3 | 1.05315973 |
55 | PAK4 | 1.03123833 |
56 | PIM1 | 1.00781127 |
57 | SMG1 | 0.97967238 |
58 | PINK1 | 0.97505822 |
59 | ITK | 0.96890395 |
60 | LATS2 | 0.94210978 |
61 | TNK2 | 0.93505157 |
62 | RPS6KB2 | 0.93008029 |
63 | TESK1 | 0.92807181 |
64 | MTOR | 0.92001898 |
65 | EPHA2 | 0.91649586 |
66 | TAOK3 | 0.91393802 |
67 | IRAK1 | 0.90726259 |
68 | CDK7 | 0.89164100 |
69 | LYN | 0.88515173 |
70 | TTK | 0.86672928 |
71 | CCNB1 | 0.85104769 |
72 | SIK2 | 0.84145783 |
73 | BMX | 0.83904471 |
74 | CLK1 | 0.83398436 |
75 | PDGFRA | 0.80941231 |
76 | BCKDK | 0.79945511 |
77 | TYRO3 | 0.75606159 |
78 | PRKD2 | 0.75594887 |
79 | TYK2 | 0.72555520 |
80 | RAF1 | 0.72067978 |
81 | MAPKAPK3 | 0.70822791 |
82 | TEC | 0.70609354 |
83 | MATK | 0.69846325 |
84 | AURKA | 0.68869559 |
85 | PLK1 | 0.68520547 |
86 | CHEK1 | 0.67868767 |
87 | CHUK | 0.66736191 |
88 | PRKCQ | 0.66403813 |
89 | EPHB1 | 0.65779284 |
90 | ARAF | 0.64529336 |
91 | RIPK1 | 0.64144408 |
92 | DAPK3 | 0.61073799 |
93 | FGFR1 | 0.60672610 |
94 | PAK2 | 0.59209778 |
95 | STK4 | 0.58447371 |
96 | IRAK2 | 0.57287556 |
97 | BTK | 0.56002592 |
98 | CDK2 | 0.55511531 |
99 | KDR | 0.55326532 |
100 | PAK1 | 0.55235819 |
101 | CDK6 | 0.54679416 |
102 | TAOK2 | 0.54429786 |
103 | AURKB | 0.54128186 |
104 | MAP3K5 | 0.53314048 |
105 | BRSK1 | 0.52585014 |
106 | DYRK1B | 0.52251905 |
107 | HCK | 0.52212167 |
108 | ZAK | 0.52155511 |
109 | ATR | 0.51586013 |
110 | JAK1 | 0.50844396 |
111 | KSR2 | 0.48633203 |
112 | RPS6KC1 | 0.47712419 |
113 | RPS6KL1 | 0.47712419 |
114 | MAPK11 | 0.47086359 |
115 | MAPKAPK2 | 0.46884440 |
116 | CAMK1D | 0.46656383 |
117 | ILK | 0.46647818 |
118 | IKBKB | 0.46165007 |
119 | LCK | 0.45416884 |
120 | MAP3K6 | 0.45168192 |
121 | RPS6KA1 | 0.44666408 |
122 | PRKD3 | 0.44518753 |
123 | PTK2 | 0.42498428 |
124 | MAP2K2 | 0.42212040 |
125 | TGFBR1 | 0.42037945 |
126 | PRKCI | 0.41599946 |
127 | MELK | 0.41005606 |
128 | SYK | 0.40086468 |
129 | PRKCH | 0.39290027 |
130 | EIF2AK3 | 0.38629585 |
131 | PDK1 | 0.37764652 |
132 | MARK2 | 0.37203289 |
133 | MARK3 | 0.36680197 |
134 | JAK2 | 0.35581432 |
135 | TGFBR2 | 0.35090545 |
136 | NEK6 | 0.34232900 |
137 | ADRBK2 | 0.33718634 |
138 | PIM2 | 0.33607588 |
139 | CDK11A | 0.33015871 |
140 | STK11 | 0.32837570 |
141 | RPS6KA2 | 0.31481278 |
142 | ABL2 | 0.31446067 |
143 | CDK15 | 0.31280812 |
144 | TXK | 0.30352369 |
145 | NME1 | 0.30301089 |
146 | RET | 0.29213783 |
147 | CDK1 | 0.26586445 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.18655427 |
2 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.77958922 |
3 | Spliceosome_Homo sapiens_hsa03040 | 2.67011806 |
4 | RNA transport_Homo sapiens_hsa03013 | 2.47867465 |
5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.38462174 |
6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.34726831 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29857304 |
8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.13817318 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.05846325 |
10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.01527488 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00777142 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.95681881 |
13 | Cell cycle_Homo sapiens_hsa04110 | 1.94207277 |
14 | Base excision repair_Homo sapiens_hsa03410 | 1.92279459 |
15 | Mismatch repair_Homo sapiens_hsa03430 | 1.89143626 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78818998 |
17 | Lysosome_Homo sapiens_hsa04142 | 1.68871391 |
18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.68003035 |
19 | Ribosome_Homo sapiens_hsa03010 | 1.62723616 |
20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62431932 |
21 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.58049576 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52009059 |
23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44295356 |
24 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.39856155 |
25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38014118 |
26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36483197 |
27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33084893 |
28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31399894 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31097658 |
30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.29735723 |
31 | HTLV-I infection_Homo sapiens_hsa05166 | 1.29598194 |
32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.29415151 |
33 | Proteasome_Homo sapiens_hsa03050 | 1.29258458 |
34 | Malaria_Homo sapiens_hsa05144 | 1.29243657 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29136645 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28116576 |
37 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.26831027 |
38 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.26698534 |
39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.26178811 |
40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.25803168 |
41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24234581 |
42 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.24104447 |
43 | Legionellosis_Homo sapiens_hsa05134 | 1.24095891 |
44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23645236 |
45 | Apoptosis_Homo sapiens_hsa04210 | 1.22448490 |
46 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.20342055 |
47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20180701 |
48 | Bladder cancer_Homo sapiens_hsa05219 | 1.19634368 |
49 | Salmonella infection_Homo sapiens_hsa05132 | 1.17917571 |
50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17253545 |
51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17169040 |
52 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.16977947 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15375511 |
54 | Shigellosis_Homo sapiens_hsa05131 | 1.14399739 |
55 | RNA polymerase_Homo sapiens_hsa03020 | 1.13485787 |
56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11676073 |
57 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.09445709 |
58 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09135791 |
59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06328897 |
60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04225193 |
61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03637840 |
62 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03466207 |
63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02936410 |
64 | Hepatitis B_Homo sapiens_hsa05161 | 1.02827991 |
65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98148815 |
66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97741034 |
67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97340609 |
68 | Phagosome_Homo sapiens_hsa04145 | 0.97310950 |
69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.97272151 |
70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.95959149 |
71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95871301 |
72 | Measles_Homo sapiens_hsa05162 | 0.95833290 |
73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.94270724 |
74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94023539 |
75 | Hepatitis C_Homo sapiens_hsa05160 | 0.92791832 |
76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92326482 |
77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91955962 |
78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91204837 |
79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90525131 |
80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87475459 |
81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87448919 |
82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87280625 |
83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87177957 |
84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87085696 |
85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86180952 |
86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85985131 |
87 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.84221483 |
88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82515553 |
89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.79591258 |
90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79377785 |
91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77379833 |
92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76461510 |
93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.74058368 |
94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73770443 |
95 | Homologous recombination_Homo sapiens_hsa03440 | 0.72620228 |
96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72544532 |
97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72327560 |
98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68888832 |
99 | Insulin resistance_Homo sapiens_hsa04931 | 0.68611103 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68054591 |
101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67884249 |
102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67272981 |
103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63996478 |
104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63927010 |
105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63924014 |
106 | Tuberculosis_Homo sapiens_hsa05152 | 0.63756685 |
107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63325222 |
108 | Basal transcription factors_Homo sapiens_hsa03022 | 0.63144221 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.62373768 |
110 | Lysine degradation_Homo sapiens_hsa00310 | 0.61800991 |
111 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61233975 |
112 | Glioma_Homo sapiens_hsa05214 | 0.60972829 |
113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60550684 |
114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60217903 |
115 | Influenza A_Homo sapiens_hsa05164 | 0.59472096 |
116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57577144 |
117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56581684 |
118 | RNA degradation_Homo sapiens_hsa03018 | 0.54333187 |
119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54225051 |
120 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53787487 |
121 | Asthma_Homo sapiens_hsa05310 | 0.53761835 |
122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53114714 |
123 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51783253 |
124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51448454 |
125 | Pertussis_Homo sapiens_hsa05133 | 0.51164657 |
126 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.50885875 |
127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49103807 |
128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47997995 |
129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46851464 |
130 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46642907 |
131 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45970629 |
132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45771674 |
133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42863080 |
134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42454970 |
135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41872781 |
136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40415892 |
137 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40115127 |
138 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39294865 |
139 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38692478 |
140 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38540531 |
141 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38281272 |